Effects of the <scp>COVID</scp>‐19 pandemic on gastroenterological surgeries in 2020: A study using the National Clinical Database of Japan
Hiromichi Maeda(Kochi Medical School Hospital), Kazuhiro Hanazaki(Kochi Medical School Hospital), Yoshihiro Kakeji(Kobe University), Yasuyuki Seto(Tokyo National Hospital), Hiroyuki Yamamoto(The University of Tokyo), Hiroki Yamaue(Wakayama Medical University), Kazuhiro Yoshida(Kyoto Institute of Technology), Hideki Endo(The University of Tokyo), Akinobu Taketomi(Hokkaido University), Yuko Kitagawa(Keio University), Hiroaki Miyata(The University of Tokyo), Masakazu Yamamoto(Tokyo Women's Medical University), Mori Masaki(Tokai University), Masaya Munekage(Kochi Medical School Hospital)
Cited by 35
Related Papers
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272